Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
NCT01976468 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-07-29
Summary
The investigators hypothesize that a low number of SCC in OTR will metastasize.
Conditions
Interventions
- OTHER
-
SCC metastasis
occurrence of SCC metastasis
Sponsors & Collaborators
-
Leiden University Medical Center
collaborator OTHER -
University of Zurich
lead OTHER
Principal Investigators
-
Günther Hofbauer, Prof MD · University Hospital Zurich, Division of Dermatology
-
Jan Nico Bouwes Bavinck · Leiden University Medical Center
-
Roel Genders, MD · Leiden University Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2023-01-31
- Completion
- 2025-01-31
Countries
- Netherlands
- Switzerland
Study Locations
More Related Trials
-
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
NCT03284424 ·Status: COMPLETED ·Phase: PHASE2
-
Towards Cure Via Only Ultra-short ICB in CSCC
NCT06823479 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
NCT06567314 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
NCT06309836 ·Status: RECRUITING
-
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
NCT05286294 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma
NCT04625205 ·Status: TERMINATED ·Phase: PHASE1
-
Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)
NCT01252329 ·Status: TERMINATED ·Phase: NA
-
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
NCT00057616 ·Status: COMPLETED ·Phase: PHASE3
-
Study With T-cel Receptor Gene Therapy in Metastatic Melanoma
NCT02654821 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
NCT04417621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine
NCT00794235 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-PD1-antibody and Pulsed HHI for Advanced BCC
NCT04679480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CCI-779 in Treating Patients With Metastatic Melanoma
NCT00022464 ·Status: COMPLETED ·Phase: PHASE2
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED
-
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
NCT07228442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
NCT05377905 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Interobserver Variability Desmoplasia
NCT06020612 ·Status: COMPLETED
-
Minimally Invasive Surgery (MIS) for Spine Metastases
NCT02367378 ·Status: COMPLETED
-
Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1
NCT04393753 ·Status: COMPLETED ·Phase: PHASE2
-
AMT-253 in Patients With Advanced Solid Tumours
NCT06209580 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs
NCT06014619 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
NCT05402059 ·Status: UNKNOWN
-
Cryoablation+Ipilimumab+Nivolumab in Melanoma
NCT05779423 ·Status: RECRUITING ·Phase: PHASE2